Hepion Pharmaceuticals Inc. (HEPA): Lastest News for HEPA recorder on Tuesday, August 04


Hepion Pharmaceuticals Inc. (NASDAQ:HEPA) changes shares on Tuesday trading session, with a change of 0.74% or $0.03 shares. The trading starts at $3.99 and closed at $4.04 throughout the day. The trading session low price was $3.96 and day high was $4.0901 on Tuesday, August 04. After the session, the Healthcare sector daily volume shifted to 0.27 million while its average volume is 1.62M. In other hand, the HEPA market cap reached to $38.30M.

On July 7, 2020, BRIEF-Hepion Pharmaceuticals Announces Preclinical Data Supporting Novel Two-Pronged Approach To Treating COVID-19 With CRV431. According to the news reported on Reuters, * HEPION PHARMACEUTICALS ANNOUNCES PRECLINICAL DATA SUPPORTING NOVEL TWO-PRONGED APPROACH TO TREATING COVID-19 WITH CRV431

Checking out the performance report which defines the increase or decrease of prices for a specific period. For the last 5 trading sessions, its performance is up 0.99% and up 41.32% for month. Its quarterly performance was 145.18% above, while its half year performance is down -20.20%. HEPA yearly performance stood at positive 69.58% and fall -24.07% for year-to-date. Current recommendation for Hepion Pharmaceuticals Inc. is 2.00.

Earnings per share or EPS is an important financial measure, which defines the profitability of a company. HEPA EPS (TTM) for 12-month is -9.51. EPS for this year is 93.70%, while for the next year its value is -1.27. Its EPS Q/Q reached 87.90%. It has an EPS of 59.90% up for past five years.

Let’s take a look on the analyst recommendations on HEPA for the current month and previous month. For the current month, 2 of 2 analysts recommend stock as Buy while 0 as Sell, 0 as overweight, 0 as underweight and 0 as Hold. As compared with the previous month ratings, 0 analysts participate in stock recommendation. Out of 0, 0 rated it sell, 0 rated it as Buy and 0 as Hold Ratings. On the other hand, target price ranges from $12.00 – $14.00. Average target price for HEPA was reached at $13.00.

The insider ownership moved to 1.64% and institutional holding shifted to 4.50%.

The company posted an EPS (TTM) of -9.51. According to the most recent quarter report on Name, HEPA analysts estimated an average EPS of Holly Energy Partners, L.P., while HEALTHWAREHOUSE.COM INC EPS posted a year ago period. Analyst Estimated EPS for HEPA published in the report was $iShares Currency Hedged MSCI EA – $Heico Corporation during the same period.

A brief look on simple moving average (SMA) that determines the market price can impact a market. The SMA for HEPA rise 21.01% for period of 200 days. SMA for 50 days was 37.90% which is showing green signal, while SMA-20 was 5.15%.